Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.
Irace, Concetta
Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes. [electronic resource] - Diabetes, obesity & metabolism 07 2020 - 1056-1061 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study
1463-1326
10.1111/dom.13993 doi
Adolescent
Adult
Blood Glucose
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1--drug therapy
Glycated Hemoglobin--analysis
Humans
Insulin
Italy
Middle Aged
Prospective Studies
Young Adult
Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes. [electronic resource] - Diabetes, obesity & metabolism 07 2020 - 1056-1061 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study
1463-1326
10.1111/dom.13993 doi
Adolescent
Adult
Blood Glucose
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1--drug therapy
Glycated Hemoglobin--analysis
Humans
Insulin
Italy
Middle Aged
Prospective Studies
Young Adult